RxDoctor Payments Data

Robert Davis, MD

Orthopaedic Surgery · Nashua, NHNPI 1578525051

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Kairos Surgical Inc at 43.6% of the total. Reporting peaked in 2021 at $1,342 and has fallen 83.3% since, to $225 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NH, where the typical reported total is $2,654.

$2,802in general payments, 2019–2025

Across 26 payments — averaging $107.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$1K
  • Stryker$1K
  • Medical Device Business Services, Inc.$195
  • Davol Inc.$84
  • Ferring Pharmaceuticals Inc.$41
  • Vertex$22
  • plus $38 from 2 others

What the payments were for

  • Travel & lodging$68324%
  • Food & beverage$91933%
  • Education$1,20043%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,802 in reported general payments places this provider in the 50th percentile of 141 orthopaedic surgery providers in New Hampshire.

See all orthopaedic surgery providers in New Hampshire →

Medicare billing

Part B allowed, 2024
$82,495
Medicare patients
235
Services billed
5,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone17$100
Meloxicam38$58
Oxycodone Hcl14$44
Tramadol Hcl13$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Nashua

See the full list for New Hampshire →

Where these figures come from

Is this you, or does something look wrong? →